122 related articles for article (PubMed ID: 36265457)
1. Changes of T Lymphocyte Subsets in Peripheral Blood of Patients with Intermediate and Advanced Cervical Cancer before and after Nimotuzumab Combined with Chemoradiotherapy.
Teng F; Cui G; Qian L; Zhao L
Int Arch Allergy Immunol; 2023; 184(1):85-97. PubMed ID: 36265457
[TBL] [Abstract][Full Text] [Related]
2. Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy.
Ao M; Li P; Sun D; Li X; Xu S; Hao Y
J Obstet Gynaecol; 2023 Dec; 43(1):2179915. PubMed ID: 37001548
[TBL] [Abstract][Full Text] [Related]
3. Effect of chemoradiotherapy on the proportion of circulating lymphocyte subsets in patients with limited-stage small cell lung cancer.
Chen Y; Jin Y; Hu X; Chen M
Cancer Immunol Immunother; 2021 Oct; 70(10):2867-2876. PubMed ID: 33674986
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
5. Research on the efficacy of cisplatin and nimotuzumab combined with concurrent chemoradiotherapy on locally advanced cervical cancer.
Cao Y; Deng L; Lian S; Jiang Y
J BUON; 2019; 24(5):2013-2019. PubMed ID: 31786869
[TBL] [Abstract][Full Text] [Related]
6. The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study.
Hu J; Chen Z; Lv J; Zheng Z; Bei Y; Chen X; Zheng L; Song W; Xu Y
Front Oncol; 2022; 12():905422. PubMed ID: 35898885
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiotherapy-Induced CD4
Chen X; Zhang W; Qian D; Guan Y; Wang Y; Zhang H; Er P; Yan C; Li Y; Ren X; Pang Q; Wang P
Front Oncol; 2019; 9():73. PubMed ID: 30828566
[No Abstract] [Full Text] [Related]
8. Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929).
Da Silva DM; Enserro DM; Mayadev JS; Skeate JG; Matsuo K; Pham HQ; Lankes HA; Moxley KM; Ghamande SA; Lin YG; Schilder RJ; Birrer MJ; Kast WM
Clin Cancer Res; 2020 Nov; 26(21):5621-5630. PubMed ID: 32816895
[TBL] [Abstract][Full Text] [Related]
9. Expression of immune cell markers and tumor markers in patients with cervical cancer.
Zhang L; Zhang H; Huang Y; Xi X; Sun Y
Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer.
Dorta-Estremera S; Colbert LE; Nookala SS; Yanamandra AV; Yang G; Delgado A; Mikkelson M; Eifel P; Jhingran A; Lilie LL; Welsh J; Schmeler K; Sastry JK; Klopp A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):593-600. PubMed ID: 30017792
[TBL] [Abstract][Full Text] [Related]
11. Clinical Efficacy of Sodium Cantharidate Vitamin B6 Combined with Concurrent Chemoradiotherapy in the Treatment of Local Advanced Cervical Cancer and its Influence on Tumor Markers.
Lu D; Chen X; Mu Y; Guo J; Zhang L
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38466067
[TBL] [Abstract][Full Text] [Related]
12. Association of lymphocyte subsets with the efficacy and prognosis of PD‑1 inhibitor therapy in advanced gastric cancer: results from a monocentric retrospective study.
Wang X; Liu X; Dai H; Jia J
BMC Gastroenterol; 2024 Mar; 24(1):113. PubMed ID: 38491354
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.
Song X; Wang S; Li J; Yan L; Chen F; Wang J
Arch Med Sci; 2021; 17(5):1317-1324. PubMed ID: 34522261
[TBL] [Abstract][Full Text] [Related]
14. Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
Thai Hoa NT; Quang Huy H
Cureus; 2020 May; 12(5):e8105. PubMed ID: 32426197
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Microwave Ablation Combined with Anti-PD-1 Monoclonal Antibody on T Cell Subsets and Long-Term Prognosis in Patients Suffering from Non-Small-Cell Lung Cancer.
Yu W; Sun J; Wang T; Du Y
Comput Math Methods Med; 2022; 2022():7095423. PubMed ID: 36199771
[TBL] [Abstract][Full Text] [Related]
17. Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
Jing W; Yan W; Liu Y; Li J; Yu J; Zhu H
Cancer Biol Ther; 2019; 20(8):1121-1126. PubMed ID: 30983494
[TBL] [Abstract][Full Text] [Related]
18. Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-
Gao L; Lv J; Hou L; Yuan Y; Wan Q
Evid Based Complement Alternat Med; 2021; 2021():1446864. PubMed ID: 34603461
[TBL] [Abstract][Full Text] [Related]
19. The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients.
Chen Z; Ding J; Pang N; Du R; Meng W; Zhu Y; Zhang Y; Ma C; Ding Y
Diagn Pathol; 2013 Apr; 8():61. PubMed ID: 23587428
[TBL] [Abstract][Full Text] [Related]
20. Cocaine Use Disorder Is Associated With Changes in Th1/Th2/Th17 Cytokines and Lymphocytes Subsets.
Zaparte A; Schuch JB; Viola TW; Baptista TAS; Beidacki AS; do Prado CH; Sanvicente-Vieira B; Bauer ME; Grassi-Oliveira R
Front Immunol; 2019; 10():2435. PubMed ID: 31749792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
